Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry.
Zhou Y, Zhang Y, Li M, Ming T, Zhang C, Huang C, Li J, Li F, Li H, Zhao E, Shu F, Liu L, Pan X, Gao Y, Tian L, Song L, Huang H, Liao W.
Zhou Y, et al. Among authors: pan x.
Sci Immunol. 2024 Oct 4;9(100):eado8758. doi: 10.1126/sciimmunol.ado8758. Epub 2024 Oct 4.
Sci Immunol. 2024.
PMID: 39365875